Literature DB >> 27803172

Type I Interferon is Pathogenic During Chronic Mycobacterium africanum Infection.

Kirsten E Wiens1,2, Joel D Ernst1,2,3.   

Abstract

Type I interferons (IFNs, including IFN-αβ) contribute to the pathogenesis of Mycobacterium tuberculosis strains that induce high IFN-αβ levels. In the current study we examined the role of IFN-αβ during infection with a Mycobacterium africanum strain that induces low IFN-β levels. We infected wild-type and IFN-αβ receptor knockout mice with M. africanum and monitored bacterial growth, lung disease, and survival over 292 days. We found reduced lung bacterial burdens and less severe histopathological findings in the absence of IFN-αβ signaling. We conclude that IFN-αβ is pathogenic during chronic M. africanum infection and that the pathogenic effects may be mediated through poorer control of bacterial growth.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  IFN-αβ; Mycobacterium africanum; tuberculosis; type I interferon

Mesh:

Substances:

Year:  2016        PMID: 27803172      PMCID: PMC5142099          DOI: 10.1093/infdis/jiw519

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling.

Authors:  Autumn G York; Kevin J Williams; Joseph P Argus; Quan D Zhou; Gurpreet Brar; Laurent Vergnes; Elizabeth E Gray; Anjie Zhen; Nicholas C Wu; Douglas H Yamada; Cameron R Cunningham; Elizabeth J Tarling; Moses Q Wilks; David Casero; David H Gray; Amy K Yu; Eric S Wang; David G Brooks; Ren Sun; Scott G Kitchen; Ting-Ting Wu; Karen Reue; Daniel B Stetson; Steven J Bensinger
Journal:  Cell       Date:  2015-12-10       Impact factor: 41.582

Review 2.  Tuberculosis pathogenesis and immunity.

Authors:  Jennifer A Philips; Joel D Ernst
Journal:  Annu Rev Pathol       Date:  2011-10-31       Impact factor: 23.472

3.  Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses.

Authors:  Rosane M B Teles; Thomas G Graeber; Stephan R Krutzik; Dennis Montoya; Mirjam Schenk; Delphine J Lee; Evangelia Komisopoulou; Kindra Kelly-Scumpia; Rene Chun; Shankar S Iyer; Euzenir N Sarno; Thomas H Rea; Martin Hewison; John S Adams; Stephen J Popper; David A Relman; Steffen Stenger; Barry R Bloom; Genhong Cheng; Robert L Modlin
Journal:  Science       Date:  2013-02-28       Impact factor: 47.728

4.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Sandra D Oland; Eduardo P Amaral; Daniel L Barber; Jacqueline Gonzales; Steven C Derrick; Ruiru Shi; Nathella Pavan Kumar; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Subash Babu; Marta Catalfamo; Andres M Salazar; Laura E Via; Clifton E Barry; Alan Sher
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

5.  Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis.

Authors:  Ludovic Desvignes; Andrea J Wolf; Joel D Ernst
Journal:  J Immunol       Date:  2012-05-07       Impact factor: 5.422

6.  Impaired fitness of Mycobacterium africanum despite secretion of ESAT-6.

Authors:  Tyler D Bold; Daphne C Davis; Kristen K Penberthy; Laura M Cox; Joel D Ernst; Bouke C de Jong
Journal:  J Infect Dis       Date:  2012-02-01       Impact factor: 5.226

Review 7.  Type I interferons in infectious disease.

Authors:  Finlay McNab; Katrin Mayer-Barber; Alan Sher; Andreas Wack; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

8.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

9.  Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis.

Authors:  Jeroen Maertzdorf; Martin Ota; Dirk Repsilber; Hans J Mollenkopf; January Weiner; Philip C Hill; Stefan H E Kaufmann
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

10.  The Mechanism for Type I Interferon Induction by Mycobacterium tuberculosis is Bacterial Strain-Dependent.

Authors:  Kirsten E Wiens; Joel D Ernst
Journal:  PLoS Pathog       Date:  2016-08-08       Impact factor: 6.823

View more
  5 in total

1.  Mycobacterium tuberculosis EspK Has Active but Distinct Roles in the Secretion of EsxA and EspB.

Authors:  Ze Long Lim; Kylee Drever; Neeraj Dhar; Stewart T Cole; Jeffrey M Chen
Journal:  J Bacteriol       Date:  2022-03-22       Impact factor: 3.476

Review 2.  Tuberculosis caused by Mycobacterium africanum: Knowns and unknowns.

Authors:  Marta L Silva; Baltazar Cá; Nuno S Osório; Pedro N S Rodrigues; Ana Raquel Maceiras; Margarida Saraiva
Journal:  PLoS Pathog       Date:  2022-05-26       Impact factor: 7.464

Review 3.  Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences.

Authors:  Meg L Donovan; Thomas E Schultz; Taylor J Duke; Antje Blumenthal
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

4.  Dynamics of Mycobacterium tuberculosis Ag85B Revealed by a Sensitive Enzyme-Linked Immunosorbent Assay.

Authors:  Joel D Ernst; Amber Cornelius; Miriam Bolz
Journal:  mBio       Date:  2019-04-23       Impact factor: 7.867

5.  MicroRNA-199a Inhibits Cellular Autophagy and Downregulates IFN-β Expression by Targeting TBK1 in Mycobacterium bovis Infected Cells.

Authors:  Jie Wang; Tariq Hussain; Ruichao Yue; Yi Liao; Qiang Li; Jiao Yao; Yinjuan Song; Xin Sun; Nan Wang; Lei Xu; Srinand Sreevatsan; Deming Zhao; Xiangmei Zhou
Journal:  Front Cell Infect Microbiol       Date:  2018-07-10       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.